Key figures

  • No.1 independent French pharmaceutical company

  • Over 21,000 employees, including nearly 3,000 in research and development, preparing the drugs of the future


  • In 2015, 24% of Servier's turnover was invested in Research and Development

  • Servier is currently developing 23 drug candidates in oncology, cardiology, metabolic diseases, neuropsychiatry and rheumatology

  • Present in 148 countries over 5 continents

  • 92% of Servier's medicines are prescribed outside France
  • A turnover of 3.9 billion euros in 2015

For more facts, including history, please visit


UK14WEB0019a(1)  DoP: February 2016